![Jui-Lien Li Huang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jui-Lien Li Huang
Investitore di Private Equity presso Ventana Capital Management LLC
Profilo
Dr. Huang is past president of the Taiwan Biotechnology Development Center for Biotechnology.
Formerly Director, Vice President and Chief Operating Officer of Canji, Inc. before assuming the leadership of the DCB, she was an independent consultant following the purchase of Canji by Schering Plough.
She has had over a decade of experience in the pharmaceutical and biotechnology industries.
Prior to joining Canji, she was a Senior Research Manager at Vical, Inc., and Research Manager at Cooper Laboratories, Inc. During her academic career, she was a Research Scientist in the Department of Medicine at the University of California, San Diego and member of the faculty in the Department of Microbiology, University of Texas Medical Branch at Galveston, Texas for 13 years.
Posizioni attive di Jui-Lien Li Huang
Società | Posizione | Inizio |
---|---|---|
Ventana Capital Management LLC
![]() Ventana Capital Management LLC Investment ManagersFinance Ventana Capital Management LLC (Ventana Capital) is a venture capital firm founded in 1984 by Tom O. Gephart. The firm is headquartered in Rancho Santa Margarita, California. | Investitore di Private Equity | 07/01/2011 |
Precedenti posizioni note di Jui-Lien Li Huang
Società | Posizione | Fine |
---|---|---|
Vical, Inc.
![]() Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Corporate Officer/Principal | - |
Canji, Inc.
![]() Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
Ventana Capital Management LLC
![]() Ventana Capital Management LLC Investment ManagersFinance Ventana Capital Management LLC (Ventana Capital) is a venture capital firm founded in 1984 by Tom O. Gephart. The firm is headquartered in Rancho Santa Margarita, California. | Finance |
Canji, Inc.
![]() Canji, Inc. Medical/Nursing ServicesHealth Services Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million. | Health Services |
Vical, Inc.
![]() Vical, Inc. Pharmaceuticals: MajorHealth Technology Vical, Inc. engages in the research and development of biopharmaceutical products based on patented DNA delivery technologies for the prevention and treatment of serious and life-threatening diseases. It focuses on the antifungal VL-2397, which treats patients with invasive aspergillosis. Its products include Vaxfectin, a cationic lipid formulation optimized to increase the immune response to vaccines. The company was founded by Howard E. Greene, Jr. Timothy J. Wollaeger, Karl Y. Hostetler, and Douglas D. Richman in April 1987 and is headquartered in San Diego, CA. | Health Technology |
- Borsa valori
- Insiders
- Jui-Lien Li Huang